No Infant Left Unprotected: Action-Ready Strategies for RSV Season 2025-26

CAN-eng

$0

gratuit

Mainpro+

1 heure

Infectious Disease, Respirology

1.0 Credits

Description du cours

RSV strikes early, but you can strike first. No Infant Left Unprotected: Action-Ready Strategies for RSV Season 2025-26 is a concise, case-based lesson that distills NACI’s universal-immunization guidance, the season-long RSV protection and proven presumptive-offer scripts that boost caregiver acceptance into an actionable playbook. In under an hour, you’ll learn how to rapidly identify and recall every at-risk infant and leave with ready-to-use strategies that ensure that no baby in your practice faces RSV unprotected.


This program has received an unrestricted educational grant or in-kind support from Sanofi Canada.

Détails du cours

Date d'expiration : 2026-09-09

Métiers: Physician, Nursing, Pharmacy, Allied Health, Medical Resident, Student, Specialist

Faculté

  • Jane Healey, MD, FRCPC
  • Jessica Chan, MD, CCFP
  • Sofia Nastis, MD, CCFP

Accréditation

This activity meets the certification criteria of the College of Family Physicians of Canada and the Quebec College of Family Physicians, a continuing professional development accrediting organization recognized by the Collège des médecins du Québec and has been approved for up to 1.0 Mainpro+® Certified Activity credit(s).

CERT+ Session ID: 301970-001

Objectif(s) d'apprentissage

Upon completion of this continuing education program, participants will be better able to:

  • Décrire the significant burden of RSV in all Canadian infants and identify infants recommended for RSV prophylaxis according to the latest NACI recommendations
  • Interpret the efficacy and real-world evidence for nirsevimab in preventing severe RSV-related outcomes
  • Apply a presumptive communication model to confidently recommend RSV immunization and effectively address caregiver questions
  • Develop practical, clinic-level processes for identifying, recalling, and immunizing eligible infants, including the “catch-up” cohort for RSV protection